4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Codexis, Inc. (CDXS) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 146 employees. Its market capitalization is roughly $160 million. In the fiscal year ended 2025-12-31, CDXS reported $70M in revenue and ($44M) in net income.
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia
Interactive charts & full statements → Open the CDXS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $70M | $59M | $70M | $139M | — |
| Gross Profit | $61M | $43M | $57M | $101M | — |
| Operating Income (EBIT) | ($38M) | ($58M) | ($55M) | ($32M) | — |
| Net Income | ($44M) | ($65M) | ($76M) | ($34M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $15M | $15M | $39M | $9M | $15M | — |
| Gross Profit | $11M | $13M | $37M | $6M | $13M | — |
| Operating Income (EBIT) | ($11M) | ($8M) | $14M | ($19M) | ($13M) | — |
| Net Income | ($12M) | ($9M) | $10M | ($20M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $148M | $149M | $137M | $250M | — |
| Total Liabilities | $97M | $82M | $50M | $106M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CDXS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms